Focus on lower urinary tract symptoms: nomenclature, diagnosis, and treatment options: highlights from the 5th international consultation on benign prostatic hyperplasia june 25-27, 2000, paris, france.
作者信息
Roehrborn C G
出版信息
Rev Urol. 2001 Summer;3(3):139-45.
Abstract
摘要
相似文献
1
2
Evaluation and treatment of lower urinary tract symptoms in older men.老年男性下尿路症状的评估和治疗。
J Urol. 2013 Jan;189(1 Suppl):S93-S101. doi: 10.1016/j.juro.2012.11.021.
3
Evaluation and treatment of lower urinary tract symptoms in older men.老年男性下尿路症状的评估与治疗
J Urol. 2009 Apr;181(4):1779-87. doi: 10.1016/j.juro.2008.11.127. Epub 2009 Feb 23.
4
Trends in Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia, 2004 to 2013: the Urologic Diseases in America Project.2004 年至 2013 年与良性前列腺增生相关的下尿路症状趋势：美国泌尿学疾病项目。
J Urol. 2020 Jan;203(1):171-178. doi: 10.1097/JU.0000000000000499. Epub 2019 Aug 20.
5
EFFICIENCY OF SILDANEFIL MONOTHERAPY IN BENIGN PROSTATIC HYPERPLASIA.
Med Pregl. 2016 Nov;69(11-12):379-383. doi: 10.2298/mpns1612379g.
6
Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.基于社区的健康老年男性人群中提示良性前列腺增生的下尿路症状的危险因素：克林彭研究
J Urol. 2009 Feb;181(2):710-6. doi: 10.1016/j.juro.2008.10.025. Epub 2008 Dec 16.
7
Evaluation and validation of the core lower urinary tract symptom score as an outcome assessment tool for the treatment of benign prostatic hyperplasia: effects of the α1-adrenoreceptor antagonist silodosin.核心下尿路症状评分作为良性前列腺增生症治疗结局评估工具的评价与验证：α1-肾上腺素能受体拮抗剂西洛多辛的作用
Int J Urol. 2014 Jan;21(1):108-12. doi: 10.1111/iju.12167. Epub 2013 May 12.
8
Direct effects of tadalafil on lower urinary tract symptoms versus indirect effects mediated through erectile dysfunction symptom improvement: integrated data analyses from 4 placebo controlled clinical studies.他达拉非对下尿路症状的直接作用与通过改善勃起功能障碍症状介导的间接作用：4 项安慰剂对照临床研究的综合数据分析。
J Urol. 2014 Feb;191(2):405-11. doi: 10.1016/j.juro.2013.09.057. Epub 2013 Oct 1.
9
Chronic Prostate Inflammation is Associated with Severity and Progression of Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms and Risk of Acute Urinary Retention.慢性前列腺炎与良性前列腺增生的严重程度和进展、下尿路症状以及急性尿潴留风险相关。
J Urol. 2016 Nov;196(5):1493-1498. doi: 10.1016/j.juro.2016.06.090. Epub 2016 Jul 1.
10
Early improvement of storage or voiding symptoms by tadalafil predicts treatment outcomes in patients with lower urinary tract symptoms from benign prostatic hyperplasia.他达拉非对良性前列腺增生所致下尿路症状患者储尿或排尿症状的早期改善情况可预测治疗效果。
Int J Urol. 2018 Mar;25(3):240-245. doi: 10.1111/iju.13487. Epub 2017 Nov 1.
引用本文的文献
1
Current consensus and controversy on the diagnosis of male lower urinary tract symptoms/benign prostatic hyperplasia.男性下尿路症状/良性前列腺增生诊断的当前共识与争议
Tzu Chi Med J. 2017 Jan-Mar;29(1):6-11. doi: 10.4103/tcmj.tcmj_3_17.
2
Adherence and Persistence Patterns in Medication Use Among Men With Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia.下尿路症状/良性前列腺增生男性用药的依从性和持续性模式
Am J Mens Health. 2017 Jan;11(1):164-169. doi: 10.1177/1557988315616676. Epub 2016 Jun 22.
3
Solitary fibrous tumors of the prostate: A case report.前列腺孤立性纤维瘤：一例报告。
Oncol Lett. 2015 Sep;10(3):1617-1619. doi: 10.3892/ol.2015.3379. Epub 2015 Jun 16.
4
Role for intravesical prostatic protrusion in lower urinary tract symptom: a fluid structural interaction analysis study.膀胱内前列腺突出在下尿路症状中的作用：一项流固耦合分析研究。
BMC Urol. 2015 Aug 19;15:86. doi: 10.1186/s12894-015-0081-y.
5
Overactive bladder and outlet obstruction in men.男性膀胱过度活动症和出口梗阻。
Curr Urol Rep. 2011 Feb;12(1):77-85. doi: 10.1007/s11934-010-0157-x.
Zotero 插件